Direkt zum Inhalt
Merck

14009C

Sigma-Aldrich

Serum Plus II Medium Supplement

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352207
NACRES:
NA.71

Sterilität

sterile-filtered

Versandbedingung

dry ice

Lagertemp.

−20°C

Allgemeine Beschreibung

Serum Plus II Medium Supplement contains a low level of Fetal Bovine Serum (FBS) in a proprietary formulation to promote cell attachment and cell growth.

Anwendung

Serum Plus II Medium Supplement is a proprietary formulation developed for researchers seeking Fetal Bovine Serum alternatives. Serum Plus II is a medium supplement that can be used as a substitute for fetal bovine serum in most cell culture applications.

Leistungsmerkmale und Vorteile

Benefits include reduced levels of inhibitors, improved lot-to-lot performance due to better control of component materials and reduced cost compared to fetal bovine serum. This lower-cost option has been tested on a range of commonly-used cell lines and it has performed equally (and sometimes better) than Fetal Bovine Serum.

Angaben zur Herstellung

Thawing
1. Remove the supplement bottles from the freezer and allow them to acclimate to room temperature for approximately 10 minutes.
2. Place each container in a 30 - 37 °C water bath or incubator. Excessive temperatures will degrade heat liable nutrients. If using a water bath, prevent the bottle caps from being completely submerged.
3. Gently swirl or shake the bottles every 10-15 minutes until the serum is completely thawed.
4. After thawing, use the supplement promptly. Liquid supplement may be stored refrigerated (2 - 8 °C) up to four weeks. To avoid freeze/thaw cycles or long periods of refrigeration, it is recommended that any unused supplement be immediately dispensed into small, useful aliquots and refrozen for future use.

Note:
Periodic agitation is crucial for optimum performance. If a bottle is not periodically shaken or swirrled as it thaws, gradients containing high concentrations of salts, proteins and lipids will form throughout the liquid portion and lead to the formation of crystalline or flocculent precipitates. These cryoprecipitates are not toxic to cell cultures, but they affect the appearance and consistency of each bottle.

Small amounts of cryoprecipitates are not uncommon, and will not affect product performance. Gently warming and mixing the supplement will generally allow the material to go back into solution.

Rechtliche Hinweise

SERUM PLUS is a trademark of Sigma-Aldrich Co. LLC

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Hans-Hermann Wessels et al.
Nature biotechnology, 38(6), 722-727 (2020-06-11)
Type VI CRISPR enzymes are RNA-targeting proteins with nuclease activity that enable specific and robust target gene knockdown without altering the genome. To define rules for the design of Cas13d guide RNAs (gRNAs), we conducted massively parallel screens targeting messenger
Mark Manzano et al.
mBio, 11(4) (2020-08-28)
Kaposi's sarcoma-associated herpesvirus (KSHV) causes primary effusion lymphoma (PEL). The cellular transcription factor (TF) interferon (IFN) regulatory factor 4 (IRF4) is an essential oncogene in PEL, but its specific role in PEL and how KSHV deregulates IRF4 remain unknown. Here
Robert A Dick et al.
PLoS pathogens, 16(1), e1008277-e1008277 (2020-01-28)
Retrovirus assembly is driven by the multidomain structural protein Gag. Interactions between the capsid domains (CA) of Gag result in Gag multimerization, leading to an immature virus particle that is formed by a protein lattice based on dimeric, trimeric, and
Hamza Celik et al.
Cancer cell, 34(5), 741-756 (2018-11-14)
How specific genetic lesions contribute to transformation of non-malignant myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDSs) to secondary acute myeloid leukemia (sAML) are poorly understood. JARID2 is lost by chromosomal deletions in a proportion of MPN/MDS cases that progress to sAML.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.